Lifestyle
- Regular exercise
- Stress management
- Adequate sleep
E2 · 17beta-Estradiol · Oestradiol
Estradiol measures the concentration of the estrogen hormone 17β-estradiol in the blood.
Reference ranges vary by sex, age, and menstrual cycle phase. Typically higher in females of reproductive age.
Estradiol (E2), also known as 17β-estradiol or oestradiol, is a potent estrogen hormone that plays a critical role in the regulation of the reproductive and metabolic systems. It is the primary estrogen in both females and males, although it is present in higher concentrations in females. E2 is synthesized mainly in the ovaries in females and in smaller amounts in the testes in males, as well as in adipose tissue and the brain. Clinically, estradiol is crucial for the development and maintenance of female reproductive tissues, bone density, and cardiovascular health. In males, it is involved in modulating libido, erectile function, and spermatogenesis. Abnormal levels of estradiol can indicate various conditions such as hypogonadism, menopause, polycystic ovary syndrome (PCOS), and certain cancers. In the context of athletic performance and biohacking, estradiol is relevant due to its influence on energy homeostasis, fat distribution, and muscle mass. Researchers have found that estradiol interacts with hypothalamic neurons to regulate thermogenesis and energy expenditure, which can impact body composition and physical performance. However, interpreting estradiol levels can be complex due to factors such as sex, age, menstrual cycle phase, and the use of hormone therapies. Time of day and fasting status may also affect measurements, and thus, consistent testing conditions are recommended for accurate assessment.
Klinische Bedeutung
Elevated estradiol levels can indicate conditions such as estrogen-producing tumors, liver disease, or hyperthyroidism. Reduced levels may suggest ovarian insufficiency, menopause, or hypogonadism.
Progressively rising estradiol levels may indicate estrogen-producing tumors or hormone therapy effects. Re-test in 4 weeks if outside the optimal range.
Progressively falling estradiol levels may suggest menopause or ovarian insufficiency.
Re-test Interval
4 weeks if outside optimal range
Note:
Consult a healthcare provider before starting any supplementation, especially if on hormone therapy.
Estradiol levels can vary throughout the day; testing should be done at the same time for consistency.
Testing Frequency
Annually for women over 40, more frequently if on hormone therapy.
Correlated with
Current research suggests that robust reference intervals for estradiol (E2) in various populations, particularly in cisgender and transgender women, remain incomplete, leading to debates on optimal targets for hormone therapy. Researchers have not yet established the specific confounders affecting E2 levels in different contexts, such as menopause or hormone therapy. Additionally, clinical questions regarding the long-term effects of E2 on metabolic health and its role in male physiology remain unanswered.
1,275
Total Citations
8
Human/RCT
3.6
Avg. Influence
2024
Latest
Researchers observed that estrogens, including 17β-estradiol (E2), are important regulators of male physiology, affecting both reproductive and non-reproductive organs. They found that estrogen signaling through specific receptors is crucial for normal male reproductive function and that disruptions can lead to reproductive pathologies. The study suggests that future research may uncover additional roles of estrogen in male health.
Researchers reviewed the effects of soy isoflavones on obesity, noting their structural similarity to estrogens. They found that isoflavones can exert weak estrogenic effects and may play a role in health benefits associated with soy consumption. The study suggests that these compounds could have positive effects on obesity and related health issues.
This review examined the neuroendocrinology of menopause, comparing changes in ovarian function across species. Researchers found that while both rodents and humans experience similar patterns of ovarian aging, the hypothalamic response to estrogen differs. The study suggests that understanding these differences may inform future research on menopause and hormone therapy.
Researchers found that estrogen plays a crucial role in maintaining energy balance and metabolic health, particularly through the action of 17β-estradiol (E2). They observed that estrogen deficiency, such as during menopause, is linked to obesity and metabolic disorders, which can be improved with estrogen therapy. The study highlights the importance of understanding estrogen signaling in both males and females for addressing metabolic diseases.
This study examined the interaction between estradiol and progesterone in breast cells, highlighting their roles in cell differentiation and growth. Researchers found that an imbalance between these hormones could promote carcinogenesis in the breast. The findings underscore the importance of hormonal balance in breast health.
Researchers investigated the metabolism of 17β-estradiol (E2) in relation to mammary carcinogenesis, finding that certain carcinogens alter E2 metabolism, leading to increased cell proliferation. They observed that a phytochemical could modulate E2 metabolism and reduce hyperproliferation. This study suggests E2 metabolism may serve as a biomarker for breast cancer risk.
This study explored how 17β-estradiol (E2) enhances memory formation in female mice through epigenetic mechanisms. Researchers found that E2's effects on memory are mediated by specific histone modifications and DNA methylation in the hippocampus. The findings highlight the complex relationship between estrogen and memory, indicating a need for further research in this area.
This study investigated the ecotoxicological effects of 17β-estradiol (E2) on chlorella algae, finding significant growth inhibition at certain concentrations. Researchers observed that E2 affected chlorophyll levels and enzymatic activity in the algae. The study also noted that chlorella could effectively degrade E2, highlighting its potential role in mitigating estrogen pollution in aquatic environments.
Researchers observed that chronic 17β-estradiol (E2) treatment in aged female rats prevented age-related increases in calcium channel activity, a biomarker of brain aging. They found that E2 treatment led to decreased expression of specific calcium channel subunits in the hippocampus. This suggests that E2 may have protective effects on cognitive health in aging females.
Researchers found that the ACI rat model of 17β-estradiol (E2)-induced mammary cancer closely resembles human breast cancer biology. They observed that E2 promotes cancer development through estrogen receptors and that dietary factors can influence this process. The study provides insights into the genetic factors affecting breast cancer susceptibility.
1
Total Trials
46
Total Enrolled
National Cancer Institute (NCI)
46
2011
Change in serum estradiol levels in postmenopausal women with high BMI
Research publications about Estradiol over time
10totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer